Please ensure Javascript is enabled for purposes of website accessibility
Search
▲ S&P 500 +---% | ▲ Stock Advisor +---%
Accessibility Log In Help
Accessibility Menu
Arrow-Thin-Down
S&P 500
6,890.89
+0.2%
+$15.73
Arrow-Thin-Down
DJI
47,706.37
+0.3%
+$161.78
Arrow-Thin-Down
NASDAQ
23,827.49
+0.8%
+$190.04
Arrow-Thin-Down
Bitcoin
113,251.00
-0.8%
-964.27
Arrow-Thin-Down
AAPL
$269.18
+0.1%
+$0.37
Arrow-Thin-Down
AMZN
$229.36
+1.1%
+$2.39
Arrow-Thin-Down
GOOG
$268.65
-0.5%
-$1.28
Arrow-Thin-Down
META
$751.94
+0.1%
+$1.12
Arrow-Thin-Down
MSFT
$542.49
+2.1%
+$10.97
Arrow-Thin-Down
NVDA
$201.03
+5.0%
+$9.54
Arrow-Thin-Down
TSLA
$460.85
+1.9%
+$8.43
Daily Stock Gainers Daily Stock Losers Most Active Stocks
Max Macaluso

Max Macaluso

TMFMassimo

Max is the Technology, Biopharma & Health Care Bureau Chief at Fool.com. Prior to joining the Fool, he completed a PhD in chemistry at the University of Cambridge and an MBA at the College des Ingenieurs.

Recent Articles by Max Macaluso

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services